Pfizer

RUXIENCE - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5119

HCPCS Code Descriptor:

Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg

Medicare Payment Limit:

The RUXIENCE Medicare Payment Limit is $20.275

Average Sale Price:

RUXIENCE ASP cost available once logged in. Ruxience is a biosimilar drug making the ASP calculation more complex. Ruxience's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The RUXIENCE Medicare Co-insurance percentage is 20%. RUXIENCE's Medicare Co-insurance amount is $4.06 per HCPCS unit.

APC Code:

The Ruxience APC Code is: 9367

APC Payment Limit:

The APC Payment Limit for RUXIENCE is available. Login to view.

Ruxience Cost Information:

Ruxience (rituximab) is aligned to the Q Code: Q5119 and is a biosimilar to the reference drug Rituxan. Q5119 became effective in July of 2020 and its WAC and AWP prices have remained steady since. The average sales price for Ruxience has dropped by over 70% since the ASP was first published. The significant decrease in Ruxience’s ASP is due to competition among the rituximab biosimilars.

ACCESS PRICING AND MORE BY REGISTERING

Ruxience’s wholesale acquisition cost (WAC) information was last updated on:
January 23, 2020
Ruxience’s average wholesale price (AWP) information was last updated on:
January 23, 2020